References in Vorinostat or placebo in combination with bortezomib in patients with multiple myeloma (VANTAGE 088): a multicentre, randomised, double-blind study - The Lancet Oncology
Summary of Phase I vorinostat trials | Download Table
Vorinostat in solid and hematologic malignancies | Journal of Hematology & Oncology | Full Text
Vorinostat - wikidoc
A trial of vorinostat for advanced mesothelioma | Cancer Research UK
Vorinostat (SAHA) | HDAC Inhibitor | MedChemExpress
Frontiers | Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi | Oncology
Targeting histone deacetylases: development of vorinostat for the treatment of cancer | Epigenomics
Phase I studies of vorinostat with ixazomib or pazopanib imply a role of antiangiogenesis-based therapy for TP53 mutant malignancies | Scientific Reports
Efficacy and toxicity of histone deacetylase inhibitors in relapsed/refractory multiple myeloma: Systematic review and meta‑analysis of clinical trials
The Mechanism of Action of the Histone Deacetylase Inhibitor Vorinostat Involves Interaction with the Insulin-Like Growth Factor Signaling Pathway
Phospholipase D1 is upregulated by vorinostat and confers resistance to vorinostat in glioblastoma - Kang - 2021 - Journal of Cellular Physiology - Wiley Online Library
Vorinostat - Wikipedia
Vorinostat and quinacrine have synergistic effects in T-cell acute lymphoblastic leukemia through reactive oxygen species increase and mitophagy inhibition | Cell Death & Disease
Delivery systems for vorinostat in cancer treatment: An updated review - ScienceDirect
Fluvastatin potentiates anticancer activity of vorinostat in renal cancer cells - Okubo - 2020 - Cancer Science - Wiley Online Library
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial - The Lancet Oncology
Table 1 from Epi-drugs to fight cancer: from chemistry to cancer treatment, the road ahead. | Semantic Scholar
Vorinostat (SAHA) in clinical trials (N/A-not analyzed). | Download Scientific Diagram
Synthesis of benzoxazole-based vorinostat analogs and their antiproliferative activity - ScienceDirect
Understanding relative survival outcomes for patients with cutaneous T-cell lymphoma (CTCL) subtypes mycosis fungoides and Sézary syndrome treated with mogamulizumab or vorinostat: combining Australian real-world evidence and MAVORIC phase 3 trial data -
Vorinostat in single agent trials | Download Table
IJMS | Free Full-Text | Targeting Histone Deacetylases to Modulate Graft-Versus-Host Disease and Graft-Versus-Leukemia | HTML
Phase I trial of vorinostat and doxorubicin in solid tumours: histone deacetylase 2 expression as a predictive marker | British Journal of Cancer
Methylation age as a correlate for allele burden, disease status, and clinical response in myeloproliferative neoplasm patients treated with vorinostat - Experimental Hematology
Clinical trials of vorinostat in combination therapy in patients with... | Download Table
